Press Releases

02.05.2018

Phase 3 PROSPER Trial Shows XTANDI® (enzalutamide) Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer

01.30.2018

Pfizer Reports Fourth-Quarter and Full-Year 2017 Results

01.24.2018

Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®

01.22.2018

MINDIMMUNE THERAPEUTICS TO CONDUCT RESEARCH ON SPECIALIZED IMMUNE CELLS WITH PFIZER INC.

01.19.2018

Survey of Ulcerative Colitis Patients and Gastroenterologists Indicates that Symptoms May Create a New Reality for Patients

01.17.2018

Circle Pharma announces publication in Journal of Medicinal Chemistry of results from collaboration with Pfizer Inc.

01.09.2018

Adapsyn Bioscience Completes Financing to Advance its Small Molecule Natural Products Platform and Pipeline; Announces Research Collaboration with Pfizer Inc.

01.08.2018

Imcyse announces a research collaboration with Pfizer Inc. in rheumatoid arthritis (RA)

01.08.2018

Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available ‘Big Data’ Human Sequencing Resource with UK Biobank

01.08.2018

Alexandria Venture Investments Launches the Alexandria Seed Capital Platform, a Novel and Innovative Seed-Stage Life Science Funding Model and a Natural Extension of Alexandria LaunchLabs

01.08.2018

Pfizer Inc. Announces Expiration and Results of its Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents

01.08.2018

Pfizer Establishes New Partnering Model for Early-Stage Academic Research